ASX Filings

Cleansing Notice

May 27, 2022

Ceasing to be a substantial holder

May 26, 2022

Change in substantial holding

May 24, 2022

Change in substantial holding

May 16, 2022

Opthea To Present at Upcoming Investor Conferences

May 11, 2022

Additional Formats

PDF Version

Opthea Presentation at The Retina World Congress 2022

May 10, 2022

Additional Formats

PDF Version

Opthea Data for OPT-302 in Combination with Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) Presented at ARVO 2022

May 5, 2022

Additional Formats

PDF Version

Change in substantial holding

May 3, 2022

Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting

April 29, 2022

Additional Formats

PDF Version

Change in substantial holding

April 28, 2022